medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 3

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (3)

Knowledge and practice on carbapenem-resistant Enterobacterales in medical doctors from a tertiary hospital in Cuba

Yu H, Hernández GA, Estévez TG, Pérez CD, Ramos RV, Han X, Baly GA, Quiñones PD

Language: Spanish
References: 20
Page:
PDF size: 639.89 Kb.


ABSTRACT

Introduction: In the context of COVID-19 pandemic, carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) infection becomes a global public health threat. Medical doctors play a fundamental role in the clinical management and control of infections caused by carbapenem-resistant pathogens. However, in Cuba there are not previous studies on the knowledge and practice of medical doctors about CR-CRE.
Objective: To study the knowledge and practice of Cuban medical doctors in a tertiary hospital about CR-CRE infections, their clinical management, prevention and control.
Methods: It was conducted an observational study (descriptive, cross-sectional) and an specific questionnaire to 70 medical doctors was applied.
Results: There was variability on the opinions about CP-CRE and average knowledge in the majority of the respondents. 58.6% of the medical doctors had some experience in the clinical management of CP-CRE infections. Knowledge gaps were associated with the limited practical experience in the management of cases. There was statistically significant difference in the level of knowledge about CP-CRE of medical doctors with experience in the management of CP-CRE compared to inexperienced medical doctors (p = 0.039).
Conclusions: It is necessary to establish a continuous training plan on this topic to improve the performance of health professionals in the control of CP-CRE infections and in the appropriate use of antibiotics.


REFERENCES

  1. Kengkla K, Wongsalap Y, Chaomuang N, Suthipinijtham P, Oberdorfer P, Saokaew S. Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients. Infect Control Hosp Epidemiol. 2021;2:1-11. DOI: https://doi.org/10.1017/ice.2021.4461.

  2. Quinones D, Hart M, Espinosa F, Garcia S, Carmona Y, Ghosh S, et al. Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba. New Microbes New Infect. 2014 [acceso 05/01/2022];2(4):123-6. Disponible en: https://www.sciencedirect.com/science/article/pii/S20522975145002002.

  3. Bastian S, Nordmann P, Creton E, Malpote E, Thiery G, Martino F, et al. First case of NDM-1 producing Klebsiella pneumoniae in Caribbean islands. Int J Infect Dis. 2015 [acceso 05/04/2022];34:53-4. Disponible en: https://www.sciencedirect.com/science/article/pii/S12019712150006363.

  4. Yu H, González Molina MK, Carmona Cartaya Y, Hart Casares M, Aung MS, Kobayashi N, et al. Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016-2021. Antibiotics. 2022 [acceso 30/04/2022];11(4):514. Disponible en: https://www.mdpi.com/2079-6382/11/4/5144.

  5. OPS/OMS. Alerta epidemiológica: Emergencia e incremento de nuevas combinaciones de carbapenemasas en Enterobacterales en Latinoamérica y el Caribe. Organización Panamericana de la Salud/Organización Mundial de la Salud; 2021.

  6. WHO. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017.

  7. Torres-Malca JR, Vera-Ponce VJ, Zuzunaga-Montoya FE, Talacera JE, de La Cruz-Vargas JA. Validez de contenido por juicio de expertos de un instrumento para medir conocimientos, actitudes y prácticas sobre el consumo de sal en la población peruana. Rev Fac Med Hum. 2022;22(2):273-9. DOI: http://dx.doi.org/10.25176/rfmh.v22i2.47687.

  8. Caycho T. Aportes a la cuantificación de la validez de contenido de cuestionarios en enfermería. Rev Cubana Enfermer. 2018 [acceso 23/12/2021];34. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03192018000200001&nrm=iso8.

  9. Koletsi D, Pandis N. Ordinal logistic regression. Am J Orthod Dentofacial Orthop. 2018;153(1):157-8. DOI: https://doi.org/10.1016/j.ajodo.2017.11.0119.

  10. Yu H, Han X, Quiñones Pérez D. La humanidad enfrenta un desastre: la resistencia antimicrobiana. Rev Habanera de Cienc Medicas. 2021 [acceso 27/03/2022];20(3). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/artcle/view/385010.

  11. Lodise T, Berger A, Altincatal A, Wang R, Bhagnani T, Gillard P, et al. Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)-Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae? Open Forum Infect Dis. 2017 [acceso 27/04/2022];4(Suppl 1):S14-S. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632073/11.

  12. CDC. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) 2015 update. Centers for Disease Control and Prevention; 2015.

  13. Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(10):2729-39. DOI: https://doi.org/10.1093/jac/dkw22113.

  14. Tacconelli E, Mazzaferri F, De Smet AM, Bragantini D, Eggimann P, Huttner BD, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019 [acceso 28/03/2022];25(7):807-17. Disponible en: https://www.sciencedirect.com/science/article/pii/S1198743X1930025414.

  15. Piñeiro Pérez R, Cilleruelo Ortega MJ, Ares Álvarez J, Baquero-Artigao F, Silva Rico JC, Velasco Zúñiga R, et al. Recomendaciones sobre el diagnóstico y tratamiento de la infección urinaria. An Pediatr. 2019 [acceso 17/04/2022];90(6):400.e1-.e9. Disponible en: https://www.sciencedirect.com/science/article/pii/S169540331930138915.

  16. Guan X, He L, Hu B, Hu J, Huang X, Lai G, et al. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect. 2016 [acceso 21/01/2022];22:S15-S25. Disponible en: https://www.sciencedirect.com/science/article/pii/S1198743X1500986616.

  17. Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy? Expert Opin Pharmacother. 2016 [acceso 21/01/2022];17(6):761-81. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970584/17.

  18. Martin A, Fahrbach K, Zhao Q, Lodise T. Association between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients with Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis. Open Forum Infect Dis. 2018;5(7). DOI: https://doi.org/10.1093/ofid/ofy15018.

  19. Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control. Infect Control Hosp Epidemiol. 2017 [acceso 15/04/2022];38(5):580-94. Disponible en: https://www.cambridge.org/core/article/carbapenemresistant-enterobacteriaceae-a-strategic-roadmap-for-infection-control/942F0B95D7849FCAFC29645D8E9C01AD19.

  20. WHO. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. World Health Organization; 2017.




2020     |     www.medigraphic.com